Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Interactive Cardiovascular and Thoracic Surgery|October 20, 2017
Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective studyFumihiro Shoji, Naoko Miura, Taichi Matsubara, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2013
Prognostic factors after complete resection of pN2 non-small cell lung cancerMakoto Sonobe, Hiroshi Date, Hiromi Wada, et al.
Ebiomedicine|June 20, 2017
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-Ichi Isa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2015
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-ichi Isa, et al.
Cancer Medicine|February 6, 2020
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer studyAkihiro Tamiya, Yasuhiro Koh, Shun-Ichi Isa, et al.
Trials|September 17, 2017
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trialHideo Saka, Chiyoe Kitagawa, Yukito Ichinose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer StudyTomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancerTatsuro Okamoto, Tokujiro Yano, Mototsugu Shimokawa, et al.
Cancer Medicine|May 22, 2023
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patientsYuka Oku, Gouji Toyokawa, Sho Wakasu, et al.
Pageof 8